For Immediate Release
Chicago, IL – July 10, 2009 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Dean Foods (DF), Hain Celestial (HAIN), United Natural Foods (UNFI), Del Monte (DLM) and Physicians Form Face (FACE).
Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=5513
Here are highlights from Thursday’s Analyst Blog:
Organic Products in Demand
On account of mounting competition from alternative channels and evolving consumer needs towards a healthier life, the natural and organic sector is gaining importance. The natural products sector (which includes organic foods, nutritional and herbal supplements, cosmetics and medicines, among other categories) generated sales of over $68 billion in 2008. Over the last five years, the natural products industry grew 8% versus 2% for the overall grocery industry. Most recently in 2008, the natural products industry grew 7.4% versus a 2% decline for the grocery industry.
Food companies like Dean Foods (DF), Hain Celestial (HAIN), United Natural Foods (UNFI) and Del Monte (DLM) are market leaders in the natural products sector, and the competition is primarily based on brand recognition, price, taste preference and quality. Acquisitions have been a key part of these companies strategy to build their market share. Acquisitions have not only expanded their geographical presence but have also provided opportunities to cross-sell products.
DF and HAIN, being the market leaders with international presence, have acquired many companies with organic product portfolios in the recent past. UNFI and DLM are the main players in the domestic market.
Similarly the natural and organic cosmetics category is also believed to be performing well and gaining importance. Physicians Form Face (FACE) has a complete range of cosmetics in the organic makeup line — from pressed powder, foundation, blush, eye shadow duo, mascara, concealer stick to makeup removers.
Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: http://at.zacks.com/?id=5515.
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Zacks “Profit from the Pros” e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: http://at.zacks.com/?id=5517
About Zacks
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it’s your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=5518.
Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Follow us on Twitter: http://twitter.com/ZacksInvestment
Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
Contact:
Mark Vickery
Web Content Editor
312-265-9380
Visit: www.zacks.com
